Cargando…

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study

BACKGROUND: The use of pharmacogenomics data is increasing in clinical practice. However, it is unknown if pharmacogenomics data can be used more broadly to predict outcomes like hospitalization or emergency department (ED) visit. We aim to determine the association between selected pharmacogenomics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Paul Y, Ryu, Euijung, Bielinski, Suzette J, Hathcock, Matthew, Jenkins, Gregory D, Cerhan, James R, Olson, Janet E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886254/ https://www.ncbi.nlm.nih.gov/pubmed/33603442 http://dx.doi.org/10.2147/PGPM.S281645

Ejemplares similares

Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank
por: Olson, Janet E., et al.
Publicado: (2018)

Quantifying the importance of disease burden on perceived general health and depressive symptoms in patients within the Mayo Clinic Biobank
por: Ryu, Euijung, et al.
Publicado: (2015)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
por: Takahashi, Paul Y, et al.
Publicado: (2021)

Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile
por: Olson, Janet E, et al.
Publicado: (2019)

Association of First Employment Characteristics and Hospitalization in the Mayo Clinic Biobank
por: Takahashi, Paul, et al.
Publicado: (2021)

Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
por: Hathcock, Matthew A., et al.
Publicado: (2020)

Employment Characteristics and Risk of Hospitalization Among Older Adults Participating in the Mayo Clinic Biobank
por: Takahashi, Paul Y., et al.
Publicado: (2022)

Association between an individual housing-based socioeconomic index and inconsistent self-reporting of health conditions: a prospective cohort study in the Mayo Clinic Biobank
por: Ryu, Euijung, et al.
Publicado: (2018)

Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank
por: Takahashi, Paul Y, et al.
Publicado: (2015)

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6
por: Takahashi, Paul Y, et al.
Publicado: (2017)

Biobanking in the emergency department: implementation of the Mayo Clinic Emergency Department Sepsis Biorepository
por: Clements, CM, et al.
Publicado: (2014)

Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol
por: Olson, Janet E., et al.
Publicado: (2017)

Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
por: St Sauver, Jennifer L, et al.
Publicado: (2023)

An assessment of patient perspectives on pharmacogenomics educational materials
por: Asiedu, Gladys B, et al.
Publicado: (2020)

How well do whole exome sequencing results correlate with medical findings? A study of 89 Mayo Clinic Biobank samples
por: Middha, Sumit, et al.
Publicado: (2015)

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
por: Giri, Jyothsna, et al.
Publicado: (2019)

Impact of Diverse Data Sources on Computational Phenotyping
por: Wang, Liwei, et al.
Publicado: (2020)

Impact of demographics on human gut microbial diversity in a US Midwest population
por: Chen, Jun, et al.
Publicado: (2016)

Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events
por: Zhu, Ye, et al.
Publicado: (2021)

Multidisciplinary Model to Implement Pharmacogenomics at the Point of Care
por: Caraballo, Pedro J., et al.
Publicado: (2016)

Association of mitochondrial DNA copy number with self-rated health status
por: Takahashi, Paul Y, et al.
Publicado: (2018)

Are patients willing to incur out of pocket costs for pharmacogenomic testing?
por: Bielinski, Suzette J., et al.
Publicado: (2016)

Applying semantic web technologies for phenome-wide scan using an electronic health record linked Biobank
por: Pathak, Jyotishman, et al.
Publicado: (2012)

A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
por: Zhu, Ye, et al.
Publicado: (2020)

Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
por: Ghosh, Pallavi, et al.
Publicado: (2023)

Department of the History of Medicine, Mayo Graduate School of Medicine
Publicado: (1971)

A 2030 Vision for the Mayo Clinic Department of Medicine
por: Caine, Natalie A., et al.
Publicado: (2022)

Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics Hypothesis
por: Breitenstein, Matthew K., et al.
Publicado: (2015)

Assessing the stability of biobank donor preferences regarding sample use: evidence supporting the value of dynamic consent
por: Pacyna, Joel E., et al.
Publicado: (2020)

Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational Research
por: Cicek, Mine S., et al.
Publicado: (2020)

Castellano-mayo, mayo-castellano
por: Collard, Howard
Publicado: (1962)

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
por: Zhu, Ye, et al.
Publicado: (2019)

Collected Papers of the Mayo Clinic and the Mayo Foundation
Publicado: (1926)

Collected Papers of the Mayo Clinic and the Mayo Foundation
Publicado: (1927)

Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004)

Sketch of the History of the Mayo Clinic and the Mayo Foundation. From the Division of Publications. Mayo Clinic
Publicado: (1928)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Clinical utility of pharmacogenomics in the management of hepatitis C
por: Trinks, Julieta, et al.
Publicado: (2014)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_62bco9pndo32q66rudh15a3odc